EDIT Editas Medicine, Inc. - Common Stock
$3,19
Harga · Agu 19, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$2–$5
53% of range
Peringkat Analis
BUY
18 analysts
Target Harga
$6
+88% upside
P/E (TTM)
-1.8
ROE
-688.8%
Margin Laba Bersih
-395.0%
Tentang Editas Medicine, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Baca selengkapnya
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
History
Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures. The name was changed to the current "Editas Medicine" two months later. Doudna quit in June 2014 over legal differences concerning intellectual property of Cas9.
In August 2015, the company raised $120 million in Series B funding from Bill Gates and 13 other investors. it went public on 2 February 2016, via a $94 million initial public offering.
Editas entered into a strategic collaboration with Juno Therapeutics in 2015 to create a chimeric antigen receptor and high-affinity T cell receptor therapeutics to the end of developing cancer therapeutics. Juno was later acquired by Celgene, which was in turn acquired by Bristol Myers Squibb.
The company announced in 2015 that it was planning a clinical trial using CRISPR gene editing techniques to treat Leber congenital amaurosis type 10 (LCA10), a rare genetic illness that causes blindness. On 30 November 2018, the FDA gave permission to start the trials, under the investigational name EDIT-101 (also known as AGN-151587). In September 2021, a statement from Editas claimed that preliminary results from clinical trials were promising and support clinical benefits of EDIT-101 treatment.
In March 2020, Editas, in partnership with Allergan, was the first to use CRISPR to try to edit DNA inside a person's body (in vivo). As part of the clinical trial, a patient who was nearly blind as a result of Leber's congenital amaurosis received an intravitreal injection containing a harmless virus carrying CRISPR gene-editing instructions. Five months later, Editas reworked its deal with Allergan's owner AbbVie and regained full rights to their range of eye disease treatment therapies, including EDIT-101 for the treatment of LCA10.
In 2019, the company was building new chemistry facilities in Boulder, Colorado.
Katrine Bosley was CEO until 2019, when she was replaced by board member Cynthia Collins. Collins was replaced in 2021 by James Mullen, who had been board chairman. Gilmore O'Neill, former CMO of Sarepta Therapeutics, became CEO on June 1, 2022, with Mullen staying on as executive chairman of the board.
On December 12, 2024, Editas ended the development of reni-cel and laid off 65% of its employees.
Research
Editas works with two different CRISPR nucleases, Cas9 and Cas12a.
EDIT-101 is a CRISPR based gene therapy for treatment of Leber congenital amaurosis, currently in clinical trials.
EDIT-301 is an experimental potential treatment utilizing the firm's CAS 12a editing technology for sickle cell disease and beta-thalassemia. In 2019 the firm reported early success in research on the drug;. In December 2020, it filed an IND application for treatment of sickle cell disease. In January 2021, it said it had received clearance from the FDA for phase 1 safety studies.
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
EDIT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$3.19
Kapitalisasi Pasar
$312M
P/E (TTM)
-1.8
EPS (TTM)
$-1.80
Pendapatan (TTM)
$41M
Imbal Hasil Dividen
—
ROE
-688.8%
D/E Utang/Ekuitas
2.1
Rentang 52M
$2 – $5
EDIT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$41M
2016-12-31
→
2025-12-31
EPS
$-1.80
2019-12-31
→
2025-12-31
Arus Kas Bebas
$-166M
2016-12-31
→
2025-12-31
Margin
-395.0%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
EDIT
Median Rekan
P/E (TTM)
-1.8
17.4
P/S (TTM)
7.7
52.3
P/B
11.4
4.8
EV / EBITDA
-1.4
—
Price / FCF (Harga / FCF)
-1.9
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
EDIT
Median Rekan
Operating Margin (Margin Operasi)
-394.9%
—
Net Profit Margin (Margin Laba Bersih)
-395.0%
-670.1%
ROA
-60.6%
-41.1%
ROE
-688.8%
-52.6%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
EDIT
Median Rekan
Debt / Equity (Utang / Ekuitas)
2.1
—
Current Ratio (Rasio Lancar)
3.5
7.7
Quick Ratio (Rasio Cepat)
3.5
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
EDIT
Median Rekan
Revenue YoY (Pendapatan YoY)
25.4%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
27.2%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
-14.9%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
EDIT
Median Rekan
EDIT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
18 analis
- Beli Kuat 4 22,2%
- Beli 8 44,4%
- Tahan 4 22,2%
- Jual 2 11,1%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
8 analis · 2026-08-16
Median
$5.00
Sekarang
$3.19
Rendah
$1.00
Tinggi
$15.00
Target median
$5.00
+57,0%
Target rata-rata
$6.00
+88,4%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.03%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.15 | $-0.28 | 0.13% |
| 31 Maret 2026 | $-0.26 | $-0.27 | 0.01% |
| 31 Des. 2025 | $-0.06 | $-0.26 | 0.20% |
| 30 Sep. 2025 | $-0.28 | $-0.30 | 0.02% |
| 30 Juni 2025 | $-0.63 | $-0.38 | -0.25% |
| 31 Maret 2025 | $-0.92 | $-0.60 | -0.32% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $32M | $78M | $20M | $26M | $91M | $21M | $32M | $14M | $6M | |
| R&D Expense | $90M | $199M | $178M | $175M | $143M | $158M | $97M | $91M | $83M | $57M | |
| SG&A Expense | $50M | $72M | $70M | $71M | $76M | $68M | $65M | $55M | $51M | $46M | |
| Operating Expenses | $201M | $283M | $247M | $246M | $219M | $226M | $161M | $146M | $134M | $103M | |
| Operating Income | $-160M | $-251M | $-169M | $-226M | $-193M | $-135M | $-141M | $-114M | $-120M | $-97M | |
| Other Non-op | $-2M | $-3.0K | $-2M | $0 | $37.0K | $16M | $-137.0K | $328.0K | $587.0K | $-57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-160M | $-237M | $-153M | $-220M | $-193M | $-116M | $-134M | $-110M | $-120M | $-97M | |
| EPS (Basic) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 | $-1.98 | $-2.68 | · | · | · | |
| EPS (Diluted) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 | $-1.98 | $-2.68 | · | · | · | |
| Shares (Basic) | 88,745,908 | 82,338,220 | 75,965,633 | 68,664,822 | 67,619,388 | 58,609,389 | 49,983,329 | · | · | · | |
| Shares (Diluted) | 88,745,908 | 82,338,220 | 75,965,633 | 68,664,822 | 67,619,388 | 58,609,389 | 49,983,329 | · | · | · | |
| EBITDA | $-160M | $-251M | $-169M | $-226M | $-193M | $-135M | $-141M | $-114M | $-120M | $-97M |
Neraca 24
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $147M | $132M | $124M | $142M | $204M | $140M | $238M | $135M | $147M | $185M | |
| Short-term Investments | $0 | $138M | $199M | $203M | $296M | $262M | $219M | $234M | $183M | · | |
| Receivables | $15M | $16M | $10M | $5M | $267.0K | $6M | $418.0K | $30.0K | $679.0K | $88.0K | |
| Prepaid Expense | $2M | $3M | $8M | $7M | $7M | $11M | $6M | $6M | $2M | $2M | |
| Current Assets | $164M | $289M | $341M | $357M | $507M | $419M | $464M | $375M | $332M | $187M | |
| PP&E (Net) | $4M | $14M | $12M | $16M | $17M | $14M | $11M | $40M | $39M | $40M | |
| PP&E (Gross) | $32M | $46M | $38M | $37M | $33M | $25M | $18M | $47M | $44M | $42M | |
| Accum. Depreciation | $28M | $32M | $26M | $22M | $16M | $11M | $7M | $7M | $4M | $2M | |
| Other Non-current Assets | $3M | $5M | $9M | $5M | $7M | $5M | $5M | $5M | $2M | $2M | |
| Total Assets | $187M | $342M | $499M | $514M | $677M | $573M | $509M | $420M | $373M | $229M | |
| Accounts Payable | $3M | $5M | $8M | $10M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Accrued Liabilities | $33M | $46M | $35M | $31M | $20M | $24M | $22M | $13M | $11M | $17M | |
| Current Liabilities | $46M | $77M | $63M | $60M | $47M | $58M | $60M | $36M | $37M | $33M | |
| Capital Leases | $12M | $20M | $24M | $33M | $16M | $19M | $23M | $32M | $33M | $35M | |
| Other Non-current Liabilities | $3M | $3M | $2M | $0 | · | $28M | $1.0K | $293.0K | $317.0K | $396.0K | |
| Total Liabilities | $159M | $207M | $150M | $154M | $124M | $179M | $246M | $184M | $165M | $95M | |
| Long-term Debt | $59M | $57M | $0 | · | · | · | · | · | · | · | |
| Total Debt | $59M | $57M | · | · | · | · | · | · | · | · | |
| Common Stock | $10.0K | $8.0K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.63B | $-1.47B | $-1.23B | $-1.08B | $-858M | $-665M | $-549M | $-416M | $-306M | $-186M | |
| AOCI | $0 | $268.0K | $198.0K | $-4M | $-493.0K | $-46.0K | $107.0K | $-29.0K | $-76.0K | · | |
| Stockholders' Equity | $27M | $134M | $349M | $361M | $554M | $394M | $262M | $236M | $208M | $135M | |
| Liabilities + Equity | $187M | $342M | $499M | $514M | $677M | $573M | $509M | $420M | $373M | $229M | |
| Shares Outstanding | 97,866,996 | 82,734,696 | 81,767,263 | 68,847,382 | 68,435,257 | 62,563,457 | 54,355,798 | 48,758,951 | 44,507,960 | 35,818,131 |
Arus Kas 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $21M | $20M | $29M | $43M | $23M | $27M | $27M | $23M | $17M | |
| Restructuring | · | $12M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-165M | $-210M | $-132M | $-177M | $-164M | $-180M | $-41M | $-46M | $-9M | $-50M | |
| CapEx | $607.0K | $9M | $5M | $4M | $8M | $7M | $6M | $5M | $2M | $3M | |
| Investing Cash Flow | $139M | $162M | $-4M | $114M | $-54M | $-141M | $12M | $-53M | $-184M | $-3M | |
| Stock Issued | $43M | $0 | $117M | $0 | $249M | $204M | $116M | $77M | $154M | $97M | |
| Net Stock Activity | $43M | $0 | $117M | · | $249M | $204M | $116M | $77M | $154M | $97M | |
| Financing Cash Flow | $40M | $56M | $118M | $1M | $282M | $224M | $132M | $87M | $155M | $97M | |
| Net Change in Cash | $14M | $8M | $-18M | $-62M | $64M | $-96M | $103M | $-12M | $-39M | $43M | |
| Free Cash Flow | $-166M | $-219M | $-137M | $-181M | $-172M | $-187M | $-47M | $-50M | $-11M | $-53M |
Profitabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | · | · | |
| Net Margin | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% | -127.8% | -651.4% | -344.3% | · | · | |
| EBITDA Margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | · | · | |
| ROA | -60.6% | -56.4% | -30.2% | -37.0% | -30.8% | -21.4% | -28.8% | -27.7% | -40.0% | -51.3% | |
| ROE | -688.8% | -153.0% | -43.2% | -56.9% | -33.8% | -27.8% | -56.6% | -47.7% | -70.2% | -377.5% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.7 | 5.4 | 5.9 | 10.8 | 7.2 | 7.7 | 10.4 | 9.1 | 5.7 | |
| Quick Ratio | 3.5 | 3.7 | 5.3 | 5.8 | 10.7 | 7.0 | 7.6 | 10.3 | 9.0 | 5.6 | |
| Debt / Equity | 2.1 | 0.4 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.0 | 0.4 | · | · | · | · | · | · | · | · |
Efisiensi 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | · | · | |
| Receivables Turnover | 2.6 | 2.4 | 10.2 | 7.3 | 8.1 | 28.1 | 91.7 | 90.1 | · | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 25.4% | -58.6% | 296.3% | -22.8% | -71.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.2% | 8.2% | -4.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.9% | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $32M | $78M | $20M | $26M | $91M | $21M | $32M | $14M | $6M | |
| Net Income TTM | $-160M | $-237M | $-153M | $-220M | $-193M | $-116M | $-134M | $-110M | $-120M | $-97M | |
| Market Cap | $201M | $105M | $828M | $611M | $1.82B | $4.39B | $1.61B | $1.11B | $1.37B | $581M | |
| Enterprise Value | $113M | $-107M | · | · | · | · | · | · | · | · | |
| P/E | -1.1 | -0.4 | -5.0 | -2.8 | -9.3 | -35.4 | -11.0 | · | · | · | |
| P/S | 5.0 | 3.3 | 10.6 | 31.0 | 71.1 | 48.3 | 78.4 | 34.7 | 99.6 | 96.0 | |
| P/B | 7.4 | 0.8 | 2.4 | 1.7 | 3.3 | 11.1 | 6.1 | 4.7 | 6.6 | 4.3 | |
| P / Tangible Book | 7.4 | 0.8 | 2.4 | 1.7 | 3.3 | 11.1 | · | · | · | · | |
| P / Cash Flow | -1.2 | -0.5 | -6.3 | -3.4 | -11.1 | -24.4 | -39.6 | -24.3 | -145.2 | -11.6 | |
| P / FCF | -1.2 | -0.5 | -6.1 | -3.4 | -10.6 | -23.5 | -34.4 | -22.0 | -119.2 | -10.9 | |
| EV / EBITDA | -0.7 | 0.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | -0.7 | 0.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | -3.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -87.8% | -226.8% | -19.9% | -36.2% | -10.7% | -2.8% | -9.0% | · | · | · |
Laporan Laba Rugi 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $3M | $25M | $8M | $4M | $5M | $31M | $61.0K | $513.0K | $1M | $60M | $5M | $3M | $10M | $7M | $42.0K | |
| R&D Expense | $20M | $18M | $27M | $20M | $16M | $27M | $49M | $48M | $54M | $49M | $70M | $41M | $30M | $38M | $52M | $41M | |
| SG&A Expense | $12M | $10M | $11M | $12M | $13M | $13M | $16M | $18M | $18M | $19M | $14M | $15M | $17M | $23M | $18M | $16M | |
| Operating Expenses | $30M | $28M | $32M | $32M | $55M | $81M | $77M | $66M | $72M | $68M | $84M | $55M | $47M | $61M | $70M | $58M | |
| Operating Income | $-19M | $-25M | $-8M | $-25M | $-52M | $-76M | $-47M | $-66M | $-72M | $-67M | $-24M | $-50M | $-44M | $-51M | $-63M | $-58M | |
| Other Non-op | $17.0K | $-113.0K | $-5.0K | $-1.0K | $-2M | $-425.0K | $-3.0K | $-5.0K | $-1.0K | $6.0K | $-13.0K | $0 | $-7.0K | $-2M | $-2.0K | $1.0K | |
| Net Income | $-18M | $-25M | $-6M | $-25M | $-53M | $-76M | $-45M | $-62M | $-68M | $-62M | $-19M | $-45M | $-40M | $-49M | $-61M | $-56M | |
| EPS (Basic) | $-0.15 | $-0.26 | $0.03 | $-0.28 | $-0.63 | $-0.92 | $-0.55 | $-0.75 | $-0.82 | $-0.76 | $-0.20 | $-0.55 | $-0.56 | $-0.71 | $-0.88 | $-0.81 | |
| EPS (Diluted) | $-0.15 | $-0.26 | $0.03 | $-0.28 | $-0.63 | $-0.92 | $-0.55 | $-0.75 | $-0.82 | $-0.76 | $-0.20 | $-0.55 | $-0.56 | $-0.71 | $-0.88 | $-0.81 | |
| Shares (Basic) | 119,294,615 | 97,879,343 | -168,811,755 | 90,090,397 | 84,412,200 | 83,055,066 | -164,396,186 | 82,485,199 | 82,310,368 | 81,938,839 | -145,983,475 | 81,648,250 | 71,376,678 | 68,924,180 | -137,197,139 | 68,736,125 | |
| Shares (Diluted) | 119,294,615 | 97,879,343 | -168,811,755 | 90,090,397 | 84,412,200 | 83,055,066 | -164,396,186 | 82,485,199 | 82,310,368 | 81,938,839 | -145,983,475 | 81,648,250 | 71,376,678 | 68,924,180 | -137,197,139 | 68,736,125 | |
| EBITDA | $-19M | $-25M | · | $-25M | $-52M | $-76M | · | $-66M | $-72M | $-67M | · | $-50M | $-44M | $-51M | · | $-58M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $124M | $147M | $166M | $139M | $139M | $132M | $96M | $64M | $69M | $124M | $83M | $221M | $129M | $142M | $211M | |
| Short-term Investments | $30M | · | $0 | $0 | $40M | $82M | $138M | $169M | $215M | $227M | $199M | $267M | $211M | $189M | · | $209M | |
| Receivables | $3M | $3M | $15M | $8M | $588.0K | $510.0K | $16M | $126.0K | $244.0K | $245.0K | $10M | $2M | $2M | $242.0K | · | $120.0K | |
| Prepaid Expense | $4M | $2M | $2M | $3M | $4M | $3M | $3M | $6M | $7M | $9M | $8M | $7M | $7M | $6M | · | $7M | |
| Current Assets | $218M | $128M | $164M | $177M | $183M | $225M | $289M | $271M | $286M | $306M | $341M | $359M | $441M | $324M | · | $427M | |
| PP&E (Net) | $3M | $3M | $4M | $4M | $5M | $8M | $14M | $15M | $14M | $13M | $12M | $12M | $13M | $13M | · | $15M | |
| PP&E (Gross) | $29M | $29M | $32M | $32M | $31M | $36M | $46M | $46M | $43M | $41M | $38M | $37M | $36M | $35M | · | $36M | |
| Accum. Depreciation | $27M | $26M | $28M | $28M | $27M | $28M | $32M | $31M | $29M | $28M | $26M | $25M | $23M | $22M | · | $20M | |
| Other Non-current Assets | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $8M | $9M | $9M | $6M | $5M | $7M | · | $8M | |
| Total Assets | $237M | $149M | $187M | $202M | $211M | $264M | $342M | $328M | $385M | $440M | $499M | $505M | $542M | $464M | · | $531M | |
| Accounts Payable | $5M | $4M | $3M | $3M | $7M | $5M | $5M | $12M | $14M | $8M | $8M | $10M | $8M | $9M | · | $7M | |
| Accrued Liabilities | $17M | $21M | $33M | $48M | $48M | $47M | $46M | $29M | $28M | $31M | $35M | $30M | $28M | $32M | · | $19M | |
| Current Liabilities | $68M | $40M | $46M | $62M | $66M | $73M | $77M | $72M | $74M | $66M | $63M | $59M | $55M | $57M | · | $42M | |
| Capital Leases | $9M | $11M | $12M | $14M | $15M | $18M | $20M | $22M | $21M | $22M | $24M | $25M | $27M | $29M | · | $9M | |
| Other Non-current Liabilities | $2M | $3M | $3M | $5M | $5M | $6M | $3M | $3M | $4M | $3M | $2M | · | · | · | · | · | |
| Total Liabilities | $132M | $145M | $159M | $188M | $191M | $201M | $207M | $152M | $153M | $146M | $150M | $144M | $142M | $147M | · | $116M | |
| Long-term Debt | $56M | $55M | $59M | $59M | $57M | $55M | $57M | · | · | · | $0 | · | · | · | · | · | |
| Total Debt | $56M | $55M | · | $59M | $57M | $55M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $15.0K | $10.0K | $10.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | · | $7.0K | |
| Retained Earnings | $-1.67B | $-1.65B | $-1.63B | $-1.62B | $-1.60B | $-1.54B | $-1.47B | $-1.42B | $-1.36B | $-1.29B | $-1.23B | $-1.21B | $-1.17B | $-1.13B | · | $-1.02B | |
| AOCI | $-6.0K | $0 | $0 | $0 | $15.0K | $88.0K | $268.0K | $522.0K | $-442.0K | $-326.0K | $198.0K | $-1M | $-2M | $-2M | · | $-4M | |
| Stockholders' Equity | $105M | $4M | $27M | $13M | $19M | $62M | $134M | $176M | $232M | $294M | $349M | $360M | $400M | $317M | $361M | $415M | |
| Liabilities + Equity | $237M | $149M | $187M | $202M | $211M | $264M | $342M | $328M | $385M | $440M | $499M | $505M | $542M | $464M | · | $531M | |
| Shares Outstanding | 97,866,996 | 97,866,996 | 97,866,996 | 93,264,421 | 87,388,425 | 83,709,536 | 82,734,696 | 82,538,624 | 82,429,514 | 82,234,951 | 81,767,263 | 81,668,796 | 81,616,909 | 68,993,591 | · | 68,761,729 |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $8M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Restructuring | · | · | · | · | · | $53M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-30M | $-23M | $-36M | $-31M | $-50M | $-48M | $-51M | $-53M | $-57M | $-50M | $-22M | $-35M | $-39M | $-36M | $-42M | $-48M | |
| CapEx | $106.0K | $92.0K | $60.0K | $433.0K | $0 | $114.0K | $540.0K | $3M | $3M | $2M | $1M | $239.0K | $1M | $2M | $624.0K | $614.0K | |
| Investing Cash Flow | $-30M | $64.0K | $58.0K | $40M | $43M | $56M | $31M | $84M | $52M | $-5M | $63M | $-103M | $13M | $23M | $-28M | $89M | |
| Stock Issued | $117M | $0 | $17M | $17M | $7M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $118M | $0 | $17M | $17M | $7M | $-1M | $56M | $0 | $322.0K | $192.0K | $514.0K | $0 | $118M | $0 | $619.0K | $80.0K | |
| Net Change in Cash | $58M | $-23M | $-19M | $26M | $-150.0K | $7M | $36M | $31M | $-5M | $-54M | $41M | $-138M | $92M | $-13M | $-69M | $41M | |
| Free Cash Flow | · | $-23M | · | · | · | $-48M | · | · | · | $-52M | · | · | · | $-38M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -156.1% | -883.2% | · | -325.4% | -1440.6% | -1635.1% | · | -107649.2% | -14016.2% | -5902.3% | · | -940.1% | -1527.3% | -517.3% | · | -136952.4% | |
| Net Margin | -153.3% | -882.4% | · | -333.0% | -1487.8% | -1633.5% | · | -101870.5% | -13178.8% | -5458.1% | · | -843.7% | -1395.6% | -497.8% | · | -132681.0% | |
| EBITDA Margin | -156.1% | -883.2% | · | -325.4% | -1440.6% | -1635.1% | · | -107649.2% | -14016.2% | -5902.3% | · | -940.1% | -1527.3% | -517.3% | · | -136952.4% | |
| ROA | -8.1% | -12.1% | · | -9.5% | -17.9% | -21.6% | · | -14.9% | -14.6% | -13.7% | · | -8.7% | -7.2% | -9.0% | · | -8.9% | |
| ROE | -29.3% | -74.8% | · | -26.6% | -42.4% | -42.6% | · | -23.2% | -21.4% | -20.2% | · | -11.6% | -9.3% | -11.8% | · | -11.1% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.2 | · | 2.9 | 2.8 | 3.1 | · | 3.7 | 3.9 | 4.6 | · | 6.1 | 8.1 | 5.7 | · | 10.1 | |
| Quick Ratio | 3.1 | 3.2 | · | 2.8 | 2.7 | 3.0 | · | 3.7 | 3.8 | 4.5 | · | 6.0 | 8.0 | 5.6 | · | 9.9 | |
| Debt / Equity | 0.5 | 12.4 | · | 4.4 | 3.0 | 0.9 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 10.7 | · | 4.0 | 2.7 | 0.8 | · | · | · | · | · | · | · | · | · | · |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 7.2 | 1.8 | · | 1.8 | 8.6 | 12.3 | · | 0.0 | 0.4 | 4.7 | · | 4.2 | 1.9 | 12.2 | · | 0.2 |
Valuasi (TTM) 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $26M | $19M | · | $16M | $9M | $6M | · | $7M | $10M | $19M | · | $18M | $19M | $23M | · | $19M | |
| Net Income TTM | $-122M | $-179M | · | $-217M | $-259M | $-268M | · | $-237M | $-215M | $-196M | · | $-190M | $-199M | $-209M | · | $-199M | |
| Market Cap | $317M | $242M | · | $324M | $192M | $97M | · | $281M | $385M | $610M | · | $637M | $672M | $500M | · | $842M | |
| Enterprise Value | $161M | $173M | · | $217M | $70M | $-69M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -1.2 | · | -1.3 | -0.7 | -0.4 | · | -1.2 | -1.7 | -2.9 | · | -3.0 | -2.9 | -2.4 | · | -4.2 | |
| P/S | 12.3 | 13.0 | · | 20.4 | 21.8 | 15.3 | · | 40.0 | 39.0 | 31.8 | · | 35.2 | 35.1 | 21.7 | · | 43.4 | |
| P/B | 3.0 | 54.8 | · | 24.1 | 10.0 | 1.6 | · | 1.6 | 1.7 | 2.1 | · | 1.8 | 1.7 | 1.6 | · | 2.0 | |
| P / Tangible Book | 3.0 | 54.8 | · | 24.1 | 10.0 | 1.6 | · | 1.6 | 1.7 | 2.1 | · | 1.8 | 1.7 | 1.6 | · | 2.0 | |
| P / Cash Flow | · | -10.5 | · | · | · | -2.0 | · | · | · | -12.2 | · | · | · | -14.0 | · | · | |
| P / FCF | · | -10.4 | · | · | · | -2.0 | · | · | · | -11.8 | · | · | · | -13.3 | · | · | |
| EV / EBITDA | -8.7 | -6.9 | · | -8.8 | -1.4 | 0.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -7.5 | · | · | · | 1.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.2 | 9.3 | · | 13.7 | 8.0 | -10.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -40.7% | -84.6% | · | -74.4% | -141.8% | -280.2% | · | -84.5% | -57.6% | -34.8% | · | -33.7% | -34.8% | -41.9% | · | -23.7% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $41M | $32M | $78M | $20M | $26M |
| Margin Operasi % | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% |
| Laba Bersih | $-160M | $-237M | $-153M | $-220M | $-193M |
| EPS Dilusian | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 2.1 | 0.4 | — | — | — |
| Rasio Lancar | 3.5 | 3.7 | 5.4 | 5.9 | 10.8 |
| Rasio Cepat | 3.5 | 3.7 | 5.3 | 5.8 | 10.7 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-166M | $-219M | $-137M | $-181M | $-172M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 239 pengaju · $327.2M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 41 (-2 vs Kuartal sebelumnya) | 22 (-4 vs Kuartal sebelumnya) | 76 (+20 vs Kuartal sebelumnya) | 42 (-9 vs Kuartal sebelumnya) | +67.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $36.000.000 | 11.111.111 | 11,00% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $28.800.360 | 8.889.000 | 8,80% | Saham |
| Commodore Capital LP | $28.800.360 | 8.889.000 | 8,80% | Saham |
| ADAR1 Capital Management, LLC | $28.800.360 | 8.889.000 | 8,80% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.897.929 | 6.141.336 | 6,08% | Saham |
| Paradigm Biocapital Advisors LP | $18.100.665 | 5.586.625 | 5,53% | Saham |
| Opaleye Management Inc. | $12.512.653 | 3.861.930 | 3,82% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11.658.618 | 3.598.339 | 3,56% | Saham |
| Woodline Partners LP | $11.519.810 | 3.555.497 | 3,52% | Saham |
| Vivo Capital, LLC | $11.519.010 | 3.555.250 | 3,52% | Saham |
| GordonMD Global Investments LP | $10.131.480 | 3.127.000 | 3,10% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $7.999.298 | 2.468.919 | 2,45% | Saham |
| Logos Global Management LP | $7.199.280 | 2.222.000 | 2,20% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $7.134.030 | 2.201.290 | 2,18% | Saham |
| STATE STREET CORP | $7.101.442 | 2.191.803 | 2,17% | Saham |
| GOLDMAN SACHS GROUP INC | $6.763.843 | 2.087.606 | 2,07% | Saham |
| TWO SIGMA INVESTMENTS, LP | $4.318.842 | 1.332.976 | 1,32% | Saham |
| Seven Fleet Capital Management LP | $4.310.820 | 1.330.500 | 1,32% | Saham |
| RAYMOND JAMES FINANCIAL INC | $4.201.156 | 1.296.653 | 1,28% | Saham |
| MARSHALL WACE, LLP | $4.044.048 | 1.248.163 | 1,24% | Saham |
| D. E. Shaw & Co., Inc. | $3.715.178 | 1.146.660 | 1,14% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.344.111 | 1.032.133 | 1,02% | Saham |
| MACKENZIE FINANCIAL CORP | $2.844.856 | 878.042 | 0,87% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.812.424 | 868.032 | 0,86% | Saham |
| Nantahala Capital Management, LLC | $2.762.748 | 852.700 | 0,84% | Saham |
| TWO SIGMA ADVISERS, LP | $2.509.405 | 1.224.100 | 0,77% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.407.158 | 742.950 | 0,74% | Saham |
| BlackRock, Inc. | $1.813.920 | 559.852 | 0,55% | Saham |
| MILLENNIUM MANAGEMENT LLC | $1.616.750 | 498.997 | 0,49% | Saham |
| Susquehanna Portfolio Strategies, LLC | $1.545.801 | 477.099 | 0,47% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.521.180 | 469.500 | 0,46% | Opsi beli |
| Eversept Partners, LP | $1.486.541 | 458.809 | 0,45% | Saham |
| Casdin Capital, LLC | $1.441.800 | 445.000 | 0,44% | Saham |
| PEAK6 LLC | $1.346.029 | 415.441 | 0,41% | Saham |
| DIADEMA PARTNERS LP | $1.296.000 | 400.000 | 0,40% | Opsi beli |
| BIT Capital GmbH | $1.056.240 | 326.000 | 0,32% | Saham |
| Cubist Systematic Strategies, LLC | $994.094 | 286.482 | 0,30% | Saham |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $878.642 | 271.186 | 0,27% | Saham |
| BANK OF AMERICA CORP /DE/ | $751.119 | 231.827 | 0,23% | Saham |
| LPL Financial LLC | $748.813 | 231.115 | 0,23% | Saham |
| Erste Asset Management GmbH | $736.000 | 230.000 | 0,22% | Saham |
| IEQ CAPITAL, LLC | $705.623 | 217.785 | 0,22% | Saham |
| Walleye Capital LLC | $595.703 | 183.859 | 0,18% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $558.900 | 172.500 | 0,17% | Opsi jual |
| CITADEL ADVISORS LLC | $557.604 | 172.100 | 0,17% | Opsi jual |
| DAFNA Capital Management LLC | $552.323 | 170.470 | 0,17% | Saham |
| Mariner, LLC | $548.500 | 169.291 | 0,17% | Saham |
| Green Alpha Advisors, LLC | $505.589 | 156.046 | 0,15% | Saham |
| PEAK6 LLC | $497.340 | 153.500 | 0,15% | Opsi beli |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $490.555 | 151.406 | 0,15% | Saham |
| BARCLAYS PLC | $476.030 | 146.923 | 0,15% | Saham |
| ALLIANCEBERNSTEIN L.P. | $464.187 | 187.930 | 0,14% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $445.030 | 137.355 | 0,14% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $408.240 | 126.000 | 0,12% | Saham |
| Point72 Asset Management, L.P. | $405.758 | 125.234 | 0,12% | Saham |
| RHUMBLINE ADVISERS | $380.421 | 117.417 | 0,12% | Saham |
| JPMORGAN CHASE & CO | $376.528 | 117.665 | 0,12% | Saham |
| JANE STREET GROUP, LLC | $374.473 | 115.578 | 0,11% | Saham |
| FMR LLC | $348.384 | 107.526 | 0,11% | Saham |
| HSBC HOLDINGS PLC | $314.481 | 97.062 | 0,10% | Saham |
| Bank of New York Mellon Corp | $309.378 | 95.487 | 0,09% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $303.462 | 93.661 | 0,09% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $300.818 | 92.845 | 0,09% | Saham |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $300.226 | 92.094 | 0,09% | Saham |
| AMERICAN CENTURY COMPANIES INC | $300.011 | 92.596 | 0,09% | Saham |
| CWM, LLC | $259.352 | 105.001 | 0,08% | Saham |
| MORGAN STANLEY | $237.324 | 73.248 | 0,07% | Saham |
| CITADEL ADVISORS LLC | $229.392 | 70.800 | 0,07% | Opsi beli |
| OSAIC HOLDINGS, INC. | $222.928 | 68.806 | 0,07% | Saham |
| SEI INVESTMENTS CO | $221.188 | 68.268 | 0,07% | Saham |
| Nuveen, LLC | $221.188 | 68.268 | 0,07% | Saham |
| Joel Isaacson & Co., LLC | $220.787 | 68.144 | 0,07% | Saham |
| JANE STREET GROUP, LLC | $218.376 | 67.400 | 0,07% | Opsi jual |
| SIMPLEX TRADING, LLC | $207.275 | 63.974 | 0,06% | Saham |
| MetLife Investment Management, LLC | $182.140 | 56.216 | 0,06% | Saham |
| CITIGROUP INC | $182.052 | 56.189 | 0,06% | Saham |
| CITADEL ADVISORS LLC | $173.923 | 53.680 | 0,05% | Saham |
| MML INVESTORS SERVICES, LLC | $168.765 | 52.088 | 0,05% | Saham |
| GROUP ONE TRADING LLC | $163.131 | 50.349 | 0,05% | Saham |
| Creative Planning | $147.653 | 45.572 | 0,05% | Saham |
| China Universal Asset Management Co., Ltd. | $143.934 | 44.424 | 0,04% | Saham |
| WINTON GROUP Ltd | $141.588 | 43.700 | 0,04% | Saham |
| Vanguard Global Advisers, LLC | $138.876 | 42.863 | 0,04% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $137.376 | 42.400 | 0,04% | Saham |
| Graham Capital Management, L.P. | $134.369 | 41.472 | 0,04% | Saham |
| Quinn Opportunity Partners LLC | $129.600 | 40.000 | 0,04% | Saham |
| Invesco Ltd. | $128.178 | 39.561 | 0,04% | Saham |
| Vanguard Personalized Indexing Management, LLC | $124.108 | 38.305 | 0,04% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $121.967 | 37.644 | 0,04% | Saham |
| Balyasny Asset Management L.P. | $121.947 | 37.638 | 0,04% | Saham |
| AXQ CAPITAL, LP | $118.104 | 36.452 | 0,04% | Saham |
| Nuveen Asset Management, LLC | $113.934 | 89.712 | 0,03% | Saham |
| SCS Capital Management LLC | $113.400 | 35.000 | 0,03% | Saham |
| Police & Firemen's Retirement System of New Jersey | $109.749 | 33.873 | 0,03% | Saham |
| Thrive Wealth Management, LLC | $108.540 | 33.500 | 0,03% | Saham |
| TWO SIGMA SECURITIES, LLC | $107.367 | 33.138 | 0,03% | Saham |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $102.359 | 31.207 | 0,03% | Saham |
| CAPTRUST FINANCIAL ADVISORS | $98.159 | 30.296 | 0,03% | Saham |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $89.683 | 27.680 | 0,03% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $88.339 | 27.265 | 0,03% | Saham |
Orang dalam perusahaan 32 orang dalam · 13 pejabat · 15 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Gilmore Neil O'Neill | CEO | 3 Juni 2026 S | 248.313 | 0 | 1 | $-41.543 |
| MULLEN JAMES C | CEO | 3 Jan. 2022 S | 75.898 | 0 | 0 | $0 |
| Cynthia Collins | CEO | 9 Feb. 2021 S | 43.760 | 0 | 0 | $0 |
| Katrine Bosley | President and CEO | 8 Jan. 2019 S | 1.204.966 | 0 | 0 | $0 |
| Michelle Robertson | Chief Financial Officer | 11 Jan. 2022 S | 31.462 | 0 | 0 | $0 |
| Andrew A. F. Hack | Chief Financial Officer | 4 Feb. 2019 M | 0 | 0 | 0 | $0 |
| Linda Burkly | EVP, CHIEF SCIENTIFIC OFFICER | 28 Juli 2026 S | 62.369 | 0 | 2 | $-15.133 |
| Bruce Eaton | EVP, Chief Business Officer | 22 Des. 2021 A | 31.498 | 0 | 0 | $0 |
| Lisa Anne Michaels | EVP/Chief Medical Officer | 22 Des. 2021 A | 22.675 | 0 | 0 | $0 |
| Mark S Shearman | EVP, Chief Scientific Officer | 22 Des. 2021 A | 41.785 | 0 | 0 | $0 |
| Judith R Abrams | Chief Medical Officer | 28 Okt. 2019 A | 25.000 | 0 | 0 | $0 |
| Vickesh Myer | Chief Technology Officer | 18 Maret 2019 M | 0 | 0 | 0 | $0 |
| Gerald Frank Cox | Chief Medical Officer | 7 Feb. 2018 A | 4.000 | 0 | 0 | $0 |
| Elliott M. Levy | Direktur | 17 Juni 2026 A | — | 0 | 0 | $0 |
| David Scadden | Direktur | 17 Juni 2026 A | — | 0 | 0 | $0 |
| Bernadette Connaughton | Direktur | 17 Juni 2026 A | — | 0 | 0 | $0 |
| Jessica Hopfield | Direktur | 17 Juni 2026 A | 22.700 | 0 | 0 | $0 |
| Andrew Hirsch | Direktur | 17 Juni 2026 A | — | 0 | 0 | $0 |
| Emma Reeve | Direktur | 3 Sep. 2021 A | — | 0 | 0 | $0 |
| Meeta Chatterjee | Direktur | 3 Juni 2021 A | — | 0 | 0 | $0 |
| Boris Nikolic | Direktur | 15 Juni 2018 A | 35.000 | 0 | 0 | $0 |
| Douglas G. Cole | Direktur | 17 Agu 2017 J | 3.171 | 0 | 0 | $0 |
| Kevin Bitterman | Direktur | 15 Juni 2017 A | 2.797.144 | 0 | 0 | $0 |
| Alexis Borisy | Direktur | 15 Juni 2017 A | 0 | 0 | 0 | $0 |
| John Mendlein | Direktur | 15 Juni 2017 A | — | 0 | 0 | $0 |
| Kevin P Starr | Pemilik 10% | 6 Sep. 2016 S | 0 | 0 | 0 | $0 |
| bng0, LLC | Pemilik 10% | 8 Feb. 2016 C | 2.649.572 | 0 | 0 | $0 |
| Patrick Thomas Ellinor II | — | 6 Agu 2026 A | — | 0 | 0 | $0 |
| Amy Parison | — | 3 Agu 2026 S | 14.292 | 0 | 2 | $-3.002 |
| Akshay Vaishnaw | — | 3 Juni 2021 A | — | 0 | 0 | $0 |
| Charles Albright | — | 15 Des. 2020 M | 24.907 | 0 | 0 | $0 |
| Alexandra Glucksmann | — | 15 Maret 2017 M | 117.788 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Polaris Venture Partners VI, L.P. (“PVP VI”), Polaris Venture Founders’ Fund VI, L.P. (“PVPFF VI”), Polaris Venture Management Co. VI, L.L.C. (“PVM VI”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Brian Chee (“Chee”), David Barrett (“Barrett”), Amir Nashat (“Nashat”), Bryce Youngren (“Youngren”) ×4 pengajuan | 18 Sep. 2017 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 28 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| GNOM · Global X Funds | 0,34% | 54.725 NS | 31 Mei 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 3.611 NS | 31 Mei 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,02% | 1.527 NS | 31 Mei 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 42.610 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 4.633 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 476.309 NS | 31 Mei 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 3.622 NS | 31 Mei 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 32.379 NS | 31 Mei 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 3.660 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 92 NS | 31 Mei 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.922 NS | 31 Mei 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 96.350 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| IWV · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWN · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IWO · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IBB · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWC · iShares Trust | — | — | 18 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 Juli 2026 | Harian |
| VHT · VANGUARD WORLD FUND | — | — | 20 Juli 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 Juli 2026 | Harian |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 20 Juli 2026 | Harian |